A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis

NCT03754309 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: KY1005
DRUG: Placebo

Sponsor

Kymab Limited